As measles cases surge to record levels in the U.S., Health and Human Services Secretary Robert F. | As measles cases surge ...

The United Kingdom is establishing a new biosecurity center designed to improve research into potentially pandemic-causing ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...

Intuitive Surgical is showing off the remote capability of its robots, with a transatlantic demonstration hosted by the ...

Novartis has ended work on ianalumab in a painful skin condition after the monoclonal antibody failed to meet “predefined ...

Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...

Momentum in Johnson & Johnson’s cardiovascular business continues while the company looks to regain its footing in the ...

The PD-1xVEGF dealmaking wave that has captivated Western pharma companies is now surging within China. | Sino Biopharm said ...

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

Otsuka Pharmaceutical is putting down $33 million cash for a Swedish biotech’s IL1RAP antibodies designed to treat autoimmune ...